MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/hed.70076

Медицинская библиотека · Head & neck · 2025

Genomic and Immune Correlates of EZH2 Expression and Activity in Olfactory Neuroblastoma.

Xue Elisabetta, Adeyelu Tolulope, Krause Harris, Elliott Andrew, Mehra Ranee, Soares Heloisa, Lou Emil, Vanderwalde Ari, Spetzler David, Bracken-Clarke Dara, London Nyall R, Gulley James L, Floudas Charalampos S

СтатьяResearch Support, N.I.H., IntramuralПеревод в очереди

Аннотация

PURPOSE: Olfactory neuroblastoma (ONB) is a rare sinonasal malignancy with limited therapeutic options in the recurrent/metastatic setting; little is known regarding its responsiveness to immunotherapy. Inhibition of enhancer of zeste homolog 2 (EZH2) has been shown to improve T-cell-mediated killing and susceptibility to immune checkpoint inhibitors in a variety of cancers. We aimed to evaluate the expression and activity of EZH2 in ONB and its association with immune characteristics.

MATERIALS AND

METHODS

We studied a cohort of 36 ONB real-world patient samples that underwent molecular profiling at a centralized lab (Caris Life Science). To infer EZH2 methyltransferase activity, we adopted an EZH2 gene repression signature (ERS) score: ONB samples were stratified into ERS-low and ERS-high subgroups, corresponding to high and low inferred EZH2 methyltransferase activity, respectively. Transcriptomic data were utilized to calculate the T-cell-inflamed (TCI) score and mitogen-activated protein kinase (MAPK) pathway activation score (MPAS). Tumor immune microenvironment composition was inferred from tumor-derived bulk RNA sequencing data. We analyzed immunologic differences between ERS-low and ERS-high ONB.

RESULTS

In ERS-high ONB, we observed a higher expression of immune-related genes, a higher proportion of TCI tumors, and an enrichment in inflammatory pathways. ERS-high ONB also displayed increased macrophages, and to a lesser extent, B cells and CD8+ T cell infiltration in the tumor microenvironment. Also, ERS-high was associated with increased MPAS, potentially identifying ONB with increased susceptibility to MAPK inhibitors. These data were confirmed in an independent validation cohort using a publicly available dataset.

CONCLUSIONS

Taken together, our data suggest that low EZH2 activity is associated with a more immunogenic microenvironment, paving the way for potential combinations of EZH2 inhibitors with checkpoint blockade in ONB.

Для цитирования: Xue Elisabetta, Adeyelu Tolulope, Krause Harris, Elliott Andrew, Mehra Ranee, Soares Heloisa, Lou Emil, Vanderwalde Ari, Spetzler David, Bracken-Clarke Dara, London Nyall R, Gulley James L, Floudas Charalampos S. Genomic and Immune Correlates of EZH2 Expression and Activity in Olfactory Neuroblastoma.. Head & neck. 2025. DOI: 10.1002/hed.70076.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.